Both the IdyllaTM IDH1-2 Mutation Assay Kit as a FastTrack method and Next-Generation Sequencing (NGS) panels play critical roles in molecular characterization of cholangiocarcinoma. The gene discussed is IDH1; the disease is cholangiocarcinoma.